1. Signaling Pathways
  2. Neuronal Signaling
  3. Monoamine Oxidase
  4. MAO-B Isoform

MAO-B

 

MAO-B Related Products (50):

Cat. No. Product Name Effect Purity
  • HY-A0091
    Pargyline hydrochloride
    Inhibitor 99.91%
    Pargyline hydrochloride is an irreversible monoamine oxidase (MAO) inhibitor with Kis of 13 μM and 0.5 μM for MAO-A and MAO-B, respectively.
  • HY-14605
    Rasagiline mesylate
    Inhibitor 99.66%
    Rasagiline (R-AGN1135) mesylate is a highly potent selective irreversible mitochondrial monoamine oxidase (MAO) inhibitor with IC50s of 4.43 nM and 412 nM for rat brain MAO B and A activity, respectively.
  • HY-70057
    Safinamide
    Inhibitor 99.95%
    Safinamide is a potent, selective, and reversible monoamine oxidase B (MAO-B) inhibitor (IC50=0.098 µM) over MAO-A (IC50=580 µM).
  • HY-14605A
    Rasagiline
    Inhibitor 99.88%
    Rasagiline (R-AGN1135) is a highly potent selective irreversible mitochondrial monoamine oxidase (MAO) inhibitor with IC50s of 4.43 nM and 412 nM for rat brain MAO B and A activity, respectively.
  • HY-A0091A
    Pargyline
    Inhibitor 99.82%
    Pargyline is an irreversible monoamine oxidase (MAO) inhibitor with Kis of 13 μM and 0.5 μM for MAO-A and MAO-B, respectively.
  • HY-17447A
    Tranylcypromine hydrochloride
    Inhibitor
    Tranylcypromine hydrochloride (SKF 385 hydrochloride) is an irreversible inhibitor of lysine-specific demethylase 1 (LSD1/BHC110) and monoamine oxidase (MAO).
  • HY-151596
    MAO-A/5-HT2AR-IN-1
    Inhibitor
    MAO-A/5-HT2AR-IN-1 (compound I14) is a potent MAO-A and 5-HT2AR dual inhibitor, with IC50 values of 0.004 and 0.014 μM, respectively.
  • HY-146314
    MAO-B-IN-9
    Inhibitor
    MAO-B-IN-9 (compound 16) is a potent, selective, BBB-penetrated, irreversible and time-dependent MAO-B (monoamine oxidase B) inhibitor, with an IC50 of 0.18 μM.
  • HY-W008566
    Norharmane
    Inhibitor 98.49%
    Norharmane (Norharman), a β-carboline alkaloid, is a potent and reversible monoamine oxidase inhibitor, with IC50 values of 6.5 and 4.7 μM for MAO-A and MAO-B, respectively.
  • HY-131036
    MAO-IN-M30 dihydrochloride
    Inhibitor 99.25%
    MAO-IN-M30 dihydrochloride is an orally active, brain-permeable, and brain selective irreversible MAO-A (IC50=37 nM) and MAO-B (IC50=57 nM) inhibitor.
  • HY-101392
    Harmane
    Inhibitor 99.81%
    Harmane, a β-Carboline alkaloid (BCA), is a potent neurotoxin that causes severe action tremors and psychiatric manifestations.
  • HY-70057A
    Safinamide mesylate
    Inhibitor 99.18%
    Safinamide (FCE 26743; EMD 1195686) mesylate is a potent, selective, and reversible monoamine oxidase B (MAO-B) inhibitor (IC50=0.098 µM) over MAO-A (IC50=580 nM).
  • HY-N9540
    Methyl citrate
    Inhibitor ≥98.0%
    Methyl citrate is a Monoamine oxidase B (MAO-B) inhibitor (IC50=0.23 mM).
  • HY-10399
    Ladostigil
    Inhibitor
    Ladostigil (TV-3326) is an orally active dual inhibitor of cholinesterase and brain-selective monoamine oxidase (MAO), with IC50s of 37.1 and 31.8 μM for MAO-B and AChE, respectively.
  • HY-B1558A
    Bifemelane hydrochloride
    Inhibitor 98.83%
    Bifemelane hydrochloride (MCI-2016) is a potent, selective and competitive inhibitor of monoamine oxidase A (MAO-A), with a Ki of 4.20 μM.
  • HY-10400
    Ladostigil hemitartrate
    Inhibitor
    Ladostigil (TV-3326) hemitartrate is an orally active dual inhibitor of cholinesterase and brain-selective monoamine oxidase (MAO), with IC50s of 37.1 and 31.8 μM for MAO-B and AChE, respectively.
  • HY-145708
    Dual AChE-MAO B-IN-2
    Inhibitor
    Dual AChE-MAO B-IN-2 is a potent AChE and MAO B dual inhibitor with IC50s of 0.12 µM and 0.01 µM for b>AChE and MAO B, respectively.
  • HY-144758
    LSD1-IN-17
    Inhibitor
    LSD1-IN-17 (compound 5b) is a potent LSD1 inhibitor.
  • HY-147953
    MAO-B-IN-13
    Inhibitor
    MAO-B-IN-13 (compound 12a) is a highly potent, reversible and blood-brain barrier (BBB) penetrant MAO-B inhibitor with an IC50 value of 10 nM.
  • HY-150563
    Neuroinflammatory-IN-2
    Inhibitor
    Neuroinflammatory-IN-2 is a potent anti-neuroinflammatory agent with an IC50 value of 10.30 μM for MAO-B, and 96.33% inhibition of 1-42 aggregation at 25 μM.